The ARC Foundation is strengthening its support for the world of immunotherapy by launching a targeted call for projects in 2018. The aim is to bring out ambitious multidisciplinary projects enabling the identification of patients and their patients. (up to € 600,000 over 3 years).
As part of its scientific strategy, the ARC Foundation aims to accelerate the secure deployment of immunotherapies throughout France, for more indications and more patients (including the pediatric population).
The first edition of this call for projects, which will be renewed in 2019 and 2020, aims to mobilize French expertise around original projects in the field of immunotherapy on complex issues relating to the identification of signatures that will guide the therapeutic decision and, at best , to select the patients to benefit from these treatments.
Return of files: June 15, 2018, at noon
Final selection: October 2018
Financing up to € 600,000
The following are some of the most important questions on the subject:
projects applied to patients treated with immunotherapy (s), excluding cell therapy:
in combination: immunotherapies with other treatments (radiotherapy, chemotherapy …);
forward-looking and / or retrospective projects
biological samples already collected and / or being collected;
data and / or databases already available.
All the terms relating to the financing conditions and the eligibility of the teams are specified in the text of the call for projects.
To apply for funding, create a folder on gap.recherche-cancer.net.
For all questions:
By email: email@example.com
By phone: 01 45 59 58 45
More information on: https://www.fondation-arc.org/sign-it